Bottom line
LYFCX vs DLHIX: the short answer
LYFCX (AlphaCentric Life Sciences and Healthcare Fund) and DLHIX (Nomura Healthcare Fund) are both mutual funds.
DLHIX is cheaper at 0.96% vs 2.41% — a difference of $145 a year per $10,000 invested.
Over five years, DLHIX returned +7.8% a year vs +4.6% for LYFCX.
Updated Nov 19, 2026
LYFCX vs DLHIX side by side
| LYFCX | DLHIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Mutual | Voya |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 2.41% | 0.96% |
| Annual cost per $10k | $241 | $96 |
| 10-yr cost on $10k (prospectus) | $3,346 | $1,232 |
| Max front load | 0% | 0% |
| 12b-1 fee | 1% | 0% |
| 1-yr return | +27.0% | +22.4% |
| 5-yr return (annualized) | +4.6% | +7.8% |
| 10-yr return (annualized) | — | +10.4% |
| Best quarter | +27.5% | — |
| Worst quarter | −11.9% | — |
| Net assets (fund) | $46.6M | $750.2M |
| Number of holdings | 62 | 108 |
| Portfolio turnover | 107% | 4% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
6 of LYFCX's top 25 holdings also appear in DLHIX's top 25.
| Holding | LYFCX | DLHIX |
|---|---|---|
| Gilead Sciences Inc | 5.53% | 3.54% |
| Vertex Pharmaceuticals Inc | 5.33% | 1.66% |
| Neurocrine Biosciences Inc | 3.51% | 1.57% |
| Abbvie Inc | 1.95% | 4.19% |
| Amgen Inc | 1.83% | 2.27% |
| Halozyme Therapeutics Inc | 1.58% | 2.30% |
Source: SEC Form N-PORT
LYFCX top 10
- Gilead Sciences Inc — 5.53%
- Vertex Pharmaceuticals Inc — 5.33%
- Astrazeneca Plc — 4.63%
- First American Funds Inc — 4.26%
- Roivant Sciences Ltd — 3.67%
- Argenx Se — 3.59%
- Neurocrine Biosciences Inc — 3.51%
- Incyte Corp — 3.51%
- Axsome Therapeutics Inc — 3.43%
- Apogee Therapeutics Inc — 3.28%
DLHIX top 10
- Ucb Sa — 5.19%
- Abbvie Inc — 4.19%
- Eli Lilly & Company — 4.16%
- Regeneron Pharmaceuticals Inc — 3.91%
- Unitedhealth Group Inc — 3.88%
- Pfizer Inc — 3.84%
- Merck & Company Inc — 3.68%
- Gilead Sciences Inc — 3.54%
- Astrazeneca Plc — 3.27%
- Elevance Health Inc — 3.25%
FAQ
What is the difference between LYFCX and DLHIX?
LYFCX (AlphaCentric Life Sciences and Healthcare Fund) and DLHIX (Nomura Healthcare Fund) are both mutual funds. DLHIX is cheaper at 0.96% vs 2.41% — a difference of $145 a year per $10,000 invested.
Which is cheaper, LYFCX or DLHIX?
DLHIX has the lower expense ratio (0.96%).
Should I own both LYFCX and DLHIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.